NCD

Philips Foundation 2022 Annual Report: partnering to provide healthcare access to over 26 million people in underserved communities

Retrieved on: 
Monday, May 15, 2023

Philips Foundation and its partners provided quality healthcare access to over 26 million people in underserved communities in 2022.

Key Points: 
  • Philips Foundation and its partners provided quality healthcare access to over 26 million people in underserved communities in 2022.
  • In 2022, 18 new initiatives were managed, deploying Philips’ expertise in healthcare technology, including initiatives supporting the people of Ukraine.
  • These investments, supported by Philips’ health technology expertise, enabled the enterprises to accelerate their potential to provide sustained access to healthcare for underserved communities.
  • Philips Foundation, in collaboration with Philips, continues to support the people of Ukraine with its partners on the ground.

Global Multiparameter Patient Monitoring Market Report 2023-2028 Featuring Key Vendors - Baxter, GE, Contec, Koninklijke Philips, Masiso, Medtronic, Nihon Kohden, OSI, & Shenzhen Mindray Bio-Medical - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 9, 2023

The increase in patient monitoring using multiparameter monitoring devices in homecare settings is expected to fuel the overall growth of the multiparameter patient monitoring market in the coming years.

Key Points: 
  • The increase in patient monitoring using multiparameter monitoring devices in homecare settings is expected to fuel the overall growth of the multiparameter patient monitoring market in the coming years.
  • Vendors in the multiparameter patient monitoring market have introduced many advanced and innovative patient monitors globally as per end-users' needs and requirements.
  • The global multiparameter patient monitoring market is highly competitive and characterized by global, regional, and local players offering multiparameter patient monitoring devices.
  • However, the key market players offering high-quality multiparameter patient monitoring devices account for considerable shares in the overall market.

Federal report finds extreme weather substantially and disproportionately impacts people with disabilities

Retrieved on: 
Thursday, May 4, 2023

The Impacts of Extreme Weather Events on People with Disabilities examines how extreme weather events and environmental hazards have adversely and disproportionately impacted people with disabilities in the United States and its territories over the past 20 years.

Key Points: 
  • The Impacts of Extreme Weather Events on People with Disabilities examines how extreme weather events and environmental hazards have adversely and disproportionately impacted people with disabilities in the United States and its territories over the past 20 years.
  • "'Weathering the storm' is more than an idiomatic expression given the frequency and intensity of extreme weather events," said NCD Chairman Andrés J. Gallegos.
  • "Rights and responsibilities under federal disability laws do not disappear due to extreme weather catastrophe," said Gallegos.
  • NCD found that during an emergency or major disaster, people  with physical, sensory, mental, or cognitive disabilities are disproportionately affected.

Alzheimer's Association Statement on Donanemab Phase 3 Topline Data Release

Retrieved on: 
Wednesday, May 3, 2023

CHICAGO, May 3, 2023 /PRNewswire/ --  On behalf of the millions of Americans impacted by the devastation of Alzheimer's disease, the Alzheimer's Association enthusiastically welcomes the robustly positive topline data reported today by Eli Lilly on the TRAILBLAZER-ALZ2 Phase 3 clinical trial of donanemab for the treatment of early symptomatic Alzheimer's disease.

Key Points: 
  • "These are the strongest phase 3 data for an Alzheimer's treatment to date.
  • For people in the earliest stages of Alzheimer's, these results suggest donanemab will significantly change the course of the disease.
  • Today's topline data is further evidence that this class of treatments can provide a meaningful benefit to people living with early Alzheimer's.
  • "We look forward to additional data from the TRAILBLAZER-ALZ2 trial at the Alzheimer's Association International Conference (AAIC) in July, including data on participant safety and representation.

900 Oral health care provider viewpoints inform latest NCD recommendations on Medicaid, Medicare

Retrieved on: 
Wednesday, April 5, 2023

Incentivizing Oral Health Care Providers to Treat Patients with Intellectual and Developmental Disabilities provides additional insights into sources and solutions regarding the difficulties of adults with I/DD in accessing quality, appropriate, and timely oral health care (OHC) services.

Key Points: 
  • Incentivizing Oral Health Care Providers to Treat Patients with Intellectual and Developmental Disabilities provides additional insights into sources and solutions regarding the difficulties of adults with I/DD in accessing quality, appropriate, and timely oral health care (OHC) services.
  • Last year, NCD published Medicaid Oral Health Coverage for Adults with Intellectual & Developmental Disabilities – A Fiscal Analysis , providing the initial results of its analysis into how to improve oral health outcomes for people with I/DD.
  • Medicare and Medicaid programs do not support dental care for adults with I/DD.
  • Dental and medical systems of health care do not support integrated health care models for people with I/DD.

NCD Academy Launches New Health Equity and Social Determinants of Health Course

Retrieved on: 
Thursday, April 6, 2023

PITTSBURGH and WASHINGTON, April 6, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and the American College of Cardiology (ACC) today released the latest NCD Academy course, Health Equity and Social Determinants of Health in NCDs, coinciding with World Health Day and the theme "Health for All." The NCD Academy is a user-friendly, interactive online platform developed by the ACC in partnership with the NCD Alliance and the World Heart Federation and sponsored by Viatris. The program is designed to equip primary healthcare professionals with educational resources and skills to enhance their ability to prevent and treat non-communicable diseases (NCDs). The NCD Academy's overarching goal is aligned with the vision to make health for all a reality, by providing continued education for skilled health workers and supporting people-centered care.

Key Points: 
  • PITTSBURGH and WASHINGTON, April 6, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, and the American College of Cardiology (ACC) today released the latest NCD Academy course, Health Equity and Social Determinants of Health in NCDs, coinciding with World Health Day and the theme "Health for All."
  • Health equity, as described by the WHO Commission on Social Determinants of Health (CSDH), is the absence of inequalities in healthcare that are avoidable by reasonable means.
  • The new Health Equity and Social Determinants of Health in NCDs course aims to educate and increase awareness of health inequities and provide support on how to address them to achieve equitable care for all.
  • "Transforming cardiovascular care and improving heart health for all needs to start with solving for health equity.

Alliance for Aging Research Criticizes CMS Decision to Restrict Access to Alzheimer's Therapies

Retrieved on: 
Thursday, February 23, 2023

CMS's decision ignores continuously mounting scientific evidence showing that these monoclonal antibodies are effective at delaying the debilitating and deadly progression of Alzheimer's.

Key Points: 
  • CMS's decision ignores continuously mounting scientific evidence showing that these monoclonal antibodies are effective at delaying the debilitating and deadly progression of Alzheimer's.
  • It abuses an extralegal paradigm called coverage with evidence development (CED) to ration access to these therapies.
  • With this decision, CMS has declared that people with Alzheimer's should have no such expectations.
  • The agency's statement reveals a stunning lack of accountability by CMS Administrator Brooks-LaSure, HHS Secretary Becerra, and the Biden Administration.

PRESS RELEASE: NCD CERTIFIED AS A GREAT PLACE TO WORK

Retrieved on: 
Thursday, February 16, 2023

The certification, conducted via surveys with NCD's employees and leadership team, revealed a stark contrast with other companies.

Key Points: 
  • The certification, conducted via surveys with NCD's employees and leadership team, revealed a stark contrast with other companies.
  • 92% of employees at NCD felt it is a great place to work, compared with 57% of employees at a typical U.S.-based company.
  • Perhaps the most significant evidence of NCD's corporate culture of inclusion and collaboration was that 96% of employees felt they could be themselves at NCD.
  • Sam Melamed, CEO of NCD, remarked upon receiving the certification, "NCD is such a positive, collaborative environment, knowing that the rest of our team sees this as a great place to work is exciting and humbling at the same time."

Diagnostic Imaging Services Market Size to Reach USD 67.94 Billion in 2030 | Emergen Research

Retrieved on: 
Monday, January 23, 2023

VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .
  • Rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry are some of the key factors boosting revenue growth of diagnostic imaging services market.
  • In addition, several product launches by key market players in diagnostic field are driving the growth of this market globally.
  • The diagnostic imaging services market is expected to register a CAGR of 5.8% over the forecast period and revenue is projected to increase from USD 40.80 in 2021 to USD 67.94 Billion in 2030.

Diagnostic Imaging Services Market Size to Reach USD 67.94 Billion in 2030 | Emergen Research

Retrieved on: 
Monday, January 23, 2023

VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Jan. 23, 2023 /PRNewswire/ -- The diagnostic imaging services market size reached USD 40.80 Billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period, according to latest analysis by Emergen Research .
  • Rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry are some of the key factors boosting revenue growth of diagnostic imaging services market.
  • In addition, several product launches by key market players in diagnostic field are driving the growth of this market globally.
  • The diagnostic imaging services market is expected to register a CAGR of 5.8% over the forecast period and revenue is projected to increase from USD 40.80 in 2021 to USD 67.94 Billion in 2030.